Medivir Ser Stock Price, News & Analysis
Company Description
Medivir Ser (OTC: MVRBF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $45.8M.
MVRBF stock has declined 8.9% over the past year.
This page provides a comprehensive overview of MVRBF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Medivir Ser (MVRBF) stock. Over the past 12 months, the stock has lost 8.9%. At a market capitalization of $45.8M, MVRBF is classified as a micro-cap stock with approximately 55.7M shares outstanding.
Latest News
Medivir Ser has 10 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial, conferences, management. View all MVRBF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
MVRBF Company Profile & Sector Positioning
Medivir Ser (MVRBF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing MVRBF often look at related companies in the same sector, including CALCIMEDICA INC (CALC), Tempest Therapeutics Inc (TPST), Verrica Pharmaceuticals (VRCA), Plus Therapeutics Inc (PSTV), and Annovis Bio Inc (ANVS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MVRBF's relative position within its industry.